SCHEMBL1585822

SCHEMBL1585822

CCn1c(=O)c(C(=O)NCC(=O)O)c(O)c2nc3ccccc3n21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 5/20 0.47
KDM4E B2RXH2 5/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HIF1A Q16665 6/20 0.43
LMNA P02545 3/20 0.42
HTT P42858 3/20 0.42
BBOX1 O75936 1/20 0.42
ASPH Q12797 1/20 0.42
KDM8 Q8N371 1/20 0.42
EGFR P00533 1/20 0.42
SRC P12931 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ALOX15 P16050 2/20 0.41
TSHR P16473 1/20 0.41
EGLN3 Q9H6Z9 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
S1PR2 O95136 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1586015 0.92 EGLN1 (0.45) EGLN1SMN1; SMN2HIF1ALMNABBOX1
SCHEMBL1586241 0.90 KDM4E (0.47) EGLN1KDM4ESMN1; SMN2LMNAHTT
SCHEMBL1586450 0.89 EGLN1 (0.44) EGLN1SMN1; SMN2HIF1ALMNAHTT
SCHEMBL1585687 0.88 EGLN1 (0.56) EGLN1EGLN3
SCHEMBL1585620 0.87 EGLN1 (0.48) EGLN1HIF1ABBOX1ASPHKDM8
SCHEMBL1585869 0.86 EGLN1 (0.47) EGLN1KDM4ESMN1; SMN2HIF1ALMNA
SCHEMBL1585825 0.85 EGLN1 (0.48) EGLN1SMN1; SMN2BBOX1ASPHKDM8
SCHEMBL1586363 0.85 EGLN1 (0.50) EGLN1HIF1AMEN1KMT2AEGLN3
SCHEMBL1585836 0.85 EGLN1 (0.48) EGLN1HIF1ABBOX1ASPHKDM8
SCHEMBL1585642 0.85 EGLN1 (0.50) EGLN1EGLN3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011048611-A1 NOVEL FUSED PYRIDAZINE DERIVATIVES TORRENT PHARMACEUTICALS LIMITED (IN) 2011-04-28 WO disclosed